Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation

被引:64
作者
Salazar, R
Solá, C
Maroto, P
Tabernero, JM
Brunet, J
Verger, G
Valentí, V
Cancelas, JA
Ojeda, B
Mendoza, L
Rodríguez, M
Montesinos, J
López-López, JJ
机构
[1] Univ Autonoma Barcelona, Hosp Santa Cruz & San Pablo, Dept Med Oncol, E-08025 Barcelona, Spain
[2] Univ Autonoma Barcelona, Hosp Santa Cruz & San Pablo, Infect Dis Unit, E-08025 Barcelona, Spain
[3] Canc Res Inst, Barcelona, Spain
关键词
bacteremia; fever; high-dose chemotherapy; imipenem; infectious complications; PBSC transplantation;
D O I
10.1038/sj.bmt.1701520
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The effect of an extensive prophylactic antimicrobial regimen was prospectively assessed in 126 patients after high-dose chemotherapy and autologous PBSC, They received ciprofloxacin (500 mg/12 h), acyclovir (200 mg/6 h), and itraconazole (200 mg/12 h) orally until neutrophil recovery, Febrile patients received i.v. imipenem (500 mg/6 h) to which vancomycin and amikacin were added if fever persisted for 2-3 and 5 days, respectively, Amphotericin B lipid complex was further given on day 7 or 8 of fever. Median times for a neutrophil count of >0.5 x 10(9)/l and a platelet count of >20 x 10(9)/l were 9 and 11 days. Severe neutropenia (<0.1 x 10(9)/l) lasted for a median of 5 days in which 72% of febrile episodes and 50% of cases of bacteremia occurred, Grampositive bacteria were isolated in 30 of 40 episodes of bacteremia, 25 of which were caused by Staphylococcus epidermidis, Clinical foci were the intravascular catheter in 35 cases, respiratory infection in 11, cellulitis in two, anal abscess in one, and neutropenic enterocolitis in one, The high incidence of febrile episodes (94%) and bacteremias (31%) may be due to the lack of efficacy of antimicrobial prophylaxis and the persistence of a 5-day period of severe neutropenia.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 51 条
[1]   A PHASE-II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN WITH AUTOLOGOUS MARROW SUPPORT IN WOMEN WITH MEASURABLE ADVANCED BREAST-CANCER RESPONDING TO STANDARD-DOSE THERAPY [J].
ANTMAN, K ;
AYASH, L ;
ELIAS, A ;
WHEELER, C ;
HUNT, M ;
EDER, JP ;
TEICHER, BA ;
CRITCHLOW, J ;
BIBBO, J ;
SCHNIPPER, LE ;
FREI, E .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :102-110
[2]  
BENEZRA D, 1988, AM J MED, V85, P495
[3]   PERIPHERAL-BLOOD STEM-CELLS (PBSCS) COLLECTED AFTER RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) - AN ANALYSIS OF FACTORS CORRELATING WITH THE TEMPO OF ENGRAFTMENT AFTER TRANSPLANTATION [J].
BENSINGER, WI ;
LONGIN, K ;
APPELBAUM, F ;
ROWLEY, S ;
WEAVER, C ;
LILLEBY, K ;
GOOLEY, T ;
LYNCH, M ;
HIGANO, T ;
KLARNET, J ;
CHAUNCEY, T ;
STORB, R ;
BUCKNER, CD .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :825-831
[4]  
BENSON K, 1993, SEMIN ONCOL, V20, P102
[6]   RETRACTED: RECONSTITUTION OF HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY BY AUTOLOGOUS PROGENITOR CELLS GENERATED EX-VIVO (RETRACTED ARTICLE. SEE VOL 345, PG 64, 2001) [J].
BRUGGER, W ;
HEIMFELD, S ;
BERENSON, RJ ;
MERTELSANN, R ;
KANZ, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :283-287
[7]   Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer [J].
Cometta, AF ;
Calandra, T ;
Gaya, H ;
Zinner, SH ;
deBock, R ;
DelFavero, A ;
Bucaneve, G ;
Crokaert, F ;
Kern, WV ;
Klastersky, J ;
Langenaeken, J ;
Micozzi, A ;
Padmos, A ;
Paesmans, M ;
Viscoli, C ;
Glauser, MP ;
Martino, P ;
Caballero, D ;
Engelhard, D ;
Shapiro, M ;
Castagnola, E ;
Massimo, L ;
Giacchino, R ;
Sanz, M ;
Gigium, M ;
Carotenuto, M ;
Lopez, A ;
Andrien, JM ;
Paulus, R ;
Martino, B ;
Nobile, F ;
Togni, P ;
Ferster, A ;
Cudillo, L ;
Legrand, JC ;
Dinota, A ;
Cajozzo, A ;
Quintini, G ;
MartinezDalmau, A ;
Nosari, A ;
Bucaneve, GP ;
Cometta, A ;
Galazzo, M ;
Giddey, M ;
Bille, J ;
Blaser, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1108-1115
[8]  
DEPAUW BE, 1990, BONE MARROW TRANSPL, V5, P179
[9]   SEPTICEMIA DUE TO XANTHOMONAS SPECIES AND NON-AERUGINOSA PSEUDOMONAS SPECIES - INCREASING INCIDENCE OF CATHETER-RELATED INFECTIONS [J].
ELTING, LS ;
BODEY, GP .
MEDICINE, 1990, 69 (05) :296-306
[10]   INTENSIVE CHEMOTHERAPY WITH HIGH-DOSES OF BCNU, ETOPOSIDE, CYTOSINE-ARABINOSIDE, AND MELPHALAN (BEAM) FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION - TOXICITY AND ANTITUMOR-ACTIVITY IN 26 PATIENTS WITH POOR-RISK MALIGNANCIES [J].
GASPARD, MH ;
MARANINCHI, D ;
STOPPA, AM ;
GASTAUT, JA ;
MICHEL, G ;
TUBIANA, N ;
BLAISE, D ;
NOVAKOVITCH, G ;
ROSSI, JF ;
WEILLER, PJ ;
SAINTY, D ;
HORCHOWSKI, N ;
CARCASSONNE, Y .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (03) :256-262